BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for SUNESIS PHARMACEUTICALS INC CO:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-12 6:47 pm Purchase |
2020-12-31 | 13G | SUNESIS PHARMACEUTICALS INC CO SNSS |
BIOTECHNOLOGY VALUE FUND L P | 1,814,308 9.980% |
1,814,308 (New Position) |
Filing |